VIVOSIM LABS, INC. (VIVS) Shareholders’ equity 2017–2026
VIVOSIM LABS, INC. (VIVS) shareholders’ equity at each fiscal year-end, per SEC filings.
-$1.1MFY2026 · since FY2017: $62.4M → -$1.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$1.1M | -110.5% |
| FY2025 | $10.5M | +191.4% |
| FY2024 | $3.6M | -76.5% |
| FY2023 | $15.3M | -49.3% |
| FY2022 | $30.2M | -22.9% |
| FY2021 | $39.2M | +47.2% |
| FY2020 | $26.6M | -26.6% |
| FY2019 | $36.3M | -18.6% |
| FY2018 | $44.6M | -28.5% |
| FY2017 | $62.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice